WELL

HAN-GINS Indxx Healthcare Innovation UCITS ETF 

"The revolutions occurring in biotechnology and AI...are redefining what it means to be human by pushing back the current thresholds of life span, health, cognition, and capabilities" - Klaus Schwab, Founder and Executive Chairman of the World Economic Forum

 

Fund Overview


HAN-GINS Indxx Healthcare Innovation ETF (WELL) is a UCITS compliant Exchange Traded Fund domiciled in Ireland.

WELL tracks the Indxx Advanced Life Sciences & Smart Healthcare Thematic Index (Net Total Return), an index designed to measure the performance of large, mid and small-capitalisation companies primarily listed on an exchange in Developed and Emerging Markets  that are involved in the Advanced Life Sciences & Smart Healthcare sector.

Please remember that the value of your investment may go down as well as up and past performance is no indication of future performance. 

 
View Related Articles

Why Invest?


  • High-conviction Megatrends

    Participate in two of the most influential structural shifts taking place in our society - Digitalisation and Aging Populations  

  • Distinctive

    Going far beyond traditional Big Pharma, WELL captures securities at the cross-roads of Medicine and Technology which are shaping the future of Healthcare 

  • Modern Portfolio Composition

    The strategy is sub-divided into eight distinctive themes identified through a rigorous research process, which include companies at the forefront of Healthcare innovation

  • True Representation

    As innovation is not determined by geographical boundaries or the size of a company, the fund includes companies from both developed and emerging markets across all market cap ranges

Tell us how we can help